Your browser doesn't support javascript.
loading
Innate local response and tissue recovery following application of high density microarray patches to human skin.
Muller, David A; Henricson, Joakim; Baker, S Ben; Togö, Totte; Jayashi Flores, Cesar M; Lemaire, Pierre A; Forster, Angus; Anderson, Chris D.
Afiliación
  • Muller DA; School of Chemistry and Molecular Biosciences, The University of Queensland, Building 76 Cooper road, St. Lucia, QLD, 4072, Australia. d.muller4@uq.edu.au.
  • Henricson J; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Baker SB; Department of Emergency Medicine, Local Health Care Services in Central Östergötland, Linköping, Sweden.
  • Togö T; Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
  • Jayashi Flores CM; Allergy Center Linköping, Region Östergötland, Sweden.
  • Lemaire PA; Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
  • Forster A; Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
  • Anderson CD; Vaxxas Pty Ltd, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Sci Rep ; 10(1): 18468, 2020 10 28.
Article en En | MEDLINE | ID: mdl-33116241
ABSTRACT
The development of microarray patches for vaccine application has the potential to revolutionise vaccine delivery. Microarray patches (MAP) reduce risks of needle stick injury, do not require reconstitution and have the potential to enhance immune responses using a fractional vaccine dose. To date, the majority of research has focused on vaccine delivery with little characterisation of local skin response and recovery. Here we study in detail the immediate local skin response and recovery of the skin post high density MAP application in 12 individuals receiving 3 MAPs randomly assigned to the forearm and upper arm. Responses were characterised by clinical scoring, dermatoscopy, evaporimetry and tissue viability imaging (TiVi). MAP application resulted in punctures in the epidermis, a significant transepidermal water loss (TEWL), the peak TEWL being concomitant with peak erythema responses visualised by TiVi. TEWL and TiVi responses reduced over time, with TEWL returning to baseline by 48 h and erythema fading over the course of a 7 day period. As MAPs for vaccination move into larger clinical studies more variation of individual subject phenotypic or disease propensity will be encountered which will require consideration both in regard to reliability of dose delivery and degree of inherent skin response.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Vacunación / Epidermis / Eritema / Parche Transdérmico Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adolescent / Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Vacunación / Epidermis / Eritema / Parche Transdérmico Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adolescent / Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Australia